Literature DB >> 18718509

Chromosomal translocations in cancer.

Mridula Nambiar1, Vijayalakshmi Kari, Sathees C Raghavan.   

Abstract

Genetic alterations in DNA can lead to cancer when it is present in proto-oncogenes, tumor suppressor genes, DNA repair genes etc. Examples of such alterations include deletions, inversions and chromosomal translocations. Among these rearrangements chromosomal translocations are considered as the primary cause for many cancers including lymphoma, leukemia and some solid tumors. Chromosomal translocations in certain cases can result either in the fusion of genes or in bringing genes close to enhancer or promoter elements, hence leading to their altered expression. Moreover, chromosomal translocations are used as diagnostic markers for cancer and its therapeutics. In the first part of this review, we summarize the well-studied chromosomal translocations in cancer. Although the mechanism of formation of most of these translocations is still unclear, in the second part we discuss the recent advances in this area of research.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18718509     DOI: 10.1016/j.bbcan.2008.07.005

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  59 in total

1.  Efficiency of nonhomologous DNA end joining varies among somatic tissues, despite similarity in mechanism.

Authors:  Sheetal Sharma; Bibha Choudhary; Sathees C Raghavan
Journal:  Cell Mol Life Sci       Date:  2010-08-03       Impact factor: 9.261

2.  Anti-apoptotic protein BCL2 down-regulates DNA end joining in cancer cells.

Authors:  Tadi Satish Kumar; Vijayalakshmi Kari; Bibha Choudhary; Mridula Nambiar; T S Akila; Sathees C Raghavan
Journal:  J Biol Chem       Date:  2010-08-10       Impact factor: 5.157

Review 3.  Chromosomes and cancer cells.

Authors:  Sarah L Thompson; Duane A Compton
Journal:  Chromosome Res       Date:  2011-04       Impact factor: 5.239

4.  DNA sense-and-respond protein modules for mammalian cells.

Authors:  Shimyn Slomovic; James J Collins
Journal:  Nat Methods       Date:  2015-09-21       Impact factor: 28.547

5.  Mechanism of fragility at BCL2 gene minor breakpoint cluster region during t(14;18) chromosomal translocation.

Authors:  Mridula Nambiar; Sathees C Raghavan
Journal:  J Biol Chem       Date:  2012-01-24       Impact factor: 5.157

Review 6.  Super-Enhancer-Driven Transcriptional Dependencies in Cancer.

Authors:  Satyaki Sengupta; Rani E George
Journal:  Trends Cancer       Date:  2017-04-12

7.  A natural compound, methyl angolensate, induces mitochondrial pathway of apoptosis in Daudi cells.

Authors:  Kishore K Chiruvella; Sathees C Raghavan
Journal:  Invest New Drugs       Date:  2010-02-20       Impact factor: 3.850

8.  G-quadruplex structures formed at the HOX11 breakpoint region contribute to its fragility during t(10;14) translocation in T-cell leukemia.

Authors:  Mridula Nambiar; Mrinal Srivastava; Vidya Gopalakrishnan; Sritha K Sankaran; Sathees C Raghavan
Journal:  Mol Cell Biol       Date:  2013-09-03       Impact factor: 4.272

9.  A novel DNA intercalator, butylamino-pyrimido[4',5':4,5]selenolo(2,3-b)quinoline, induces cell cycle arrest and apoptosis in leukemic cells.

Authors:  M S Shahabuddin; Mridula Nambiar; Bibha Choudhary; Gopal M Advirao; Sathees C Raghavan
Journal:  Invest New Drugs       Date:  2009-01-14       Impact factor: 3.850

10.  A unique cytogenetic abnormality, t(2;7)(p13.1;p21.3), in a Philadelphia-positive chronic myeloid leukemia.

Authors:  Walid Al-Achkar; Abdulsamad Wafa; Faten Moassass; Thomas Liehr
Journal:  Oncol Lett       Date:  2012-05-17       Impact factor: 2.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.